Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Progress, Challenges, and Prospects

Non-small cell lung cancer is one of the most common types of malignances worldwide and the main cause of cancer-related deaths. Current treatment for NSCLC is based on surgical resection, chemotherapy, radiotherapy, and targeted therapy, with poor therapeutic effectiveness. In recent years, immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Shengjie, Qin, Chao, Hu, Haiyang, Liu, Tao, He, Yiwei, Guo, Haiyang, Yan, Hang, Zhang, Jun, Tang, Shoujun, Zhou, Haining
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834198/
https://www.ncbi.nlm.nih.gov/pubmed/35159131
http://dx.doi.org/10.3390/cells11030320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834198/
https://www.ncbi.nlm.nih.gov/pubmed/35159131
http://dx.doi.org/10.3390/cells11030320

Ejemplares similares